Trans-splicing is a common phenomenon in nematodes and kinetoplastids, and it has also been reported in other organisms, including humans. Up to now, all in silico strategies to find evidence of trans-splicing in humans have required that the candidate sequences follow the consensus splicing site rules (spliceosome-mediated mechanism). However, this criterion is not supported by the best human experimental evidence, which, except in a single case, do not follow canonical splicing sites. Moreover, recent findings describe a novel alternative tRNA mediated transsplicing mechanism, which prescinds the spliceosome machinery. In order to answer the question, 'Are there hybrid mRNAs in sequence databanks, whose characteristics resemble those of the best human experimental evidence?', we have developed a methodology that successfully identified 16 hybrid mRNAs which might be instances of interchromosomal trans-splicing. Each hybrid mRNA is formed by a trans-spliced region (TSR), which was successfully mapped either onto known genes or onto a human endogenous retrovirus (HERV-K) transcript which supports their transcription. The existence of these hybrid mRNAs indicates that trans-splicing may be more widespread than believed. Furthermore, non-canonical splice site patterns suggest that infrequent splicing sites may occur under special conditions, or that an alternative trans-splicing mechanism is involved. Finally, our candidates are supposedly from normal tissue, and a recent study has reported that trans-splicing may occur not only in malignant tissues, but in normal tissues as well. Our methodology can be applied to 5 0 -UTR, coding sequences and 3 0 -UTR in order to find new candidates for a posteriori experimental confirmation.
BACKGROUND
Trans-splicing is an unusual form of RNA splicing, where distinct pre-mRNA transcripts contribute to a single mRNA formation. Although less frequent and less well understood than cis-splicing, transsplicing has gained momentum owing to its promising applications. For example, trans-splicing has been applied to correct genetic defects in some species without the unwanted side-effects of unregulated expression of the target genes [1] , and it has been used in a variety of human health applications reported in the specialized literature [2] [3] [4] [5] [6] [7] [8] [9] [10] .
In 1993, Bonen [11] proposed two trans-splicing categories: the spliced leader (SL), and the discontinuous group II intron. The first type is common in organisms such as nematodes [12] and kinetoplastids [13] , where a short leader sequence is trans-spliced into an untranslated mRNA 5 0 region (5 0 UTR). The other type is found in plants, algal chloroplasts and plant mitochondria, and involves the joining of independently transcribed coding sequences. Both categories follow consensus splicing site rules which resemble conventional spliceosome-mediated cis-splicing. In the last few years, evidence in other organisms has shown that, although a rare phenomenon, trans-splicing may be more widespread than believed.
Trans-splicing has been reported in Drosophila by Labrador et al. [14] and by Horiuchi and Aigaki [15] , who observed that the trans-splicing phenomenon occurred after independently transcribed premRNAs formed double-stranded RNA through complementary sequences in the mod(mdg4) gene. A similar mechanism [16] has been described, where the directed repetitive sequences that flanked two distinct genes approximated their respective pre-mRNAs in order to accomplish a trans-splicing event. Robertson et al. [17] found the first, and, to the best of our knowledge, only instance of transsplicing in mosquitoes involving an internal gene's exons from distinct chromosomal loci.
Trans-splicing was reported in mammalian cells for the first time in rat liver [18] . Rigatti et al. [19] analyzed two rat genes that have tandem repeated exons, and, as the tandem exons were not observed in the respective genomic region, the authors proposed trans-splicing as a possible explanation. Evidence of intrachromosomal trans-splicing has been reported in cattle [20] . It is worth noting that heterologous mRNA hybrids were generated by mRNA trans-splicing, or the transcription of long mRNA across neighboring loci. It is interesting that independent work [21] has revealed that, in fact, the proximity of different transcripts can facilitate the occurrence of trans-splicing.
The diversity of trans-splicing phenomena in mammals is frequently associated with cancer, an association that has been studied by Chen et al. [22] , who analyzed the structure of abnormal MYC mRNA genes related to tumoral cells, and concluded that the anomalous transcripts are usually generated by trans-splicing. Hahn et al. [23] , using an EST library, found several fused genes from chromosome rearrangement, and unexpectedly, identified some cases that might be evidence of trans-splicing in normal tissues.
Canonical splicing sites worthy of note have been observed in all the studies mentioned. Rather interestingly, however, all but one reported that human experimental evidence fails to follow canonical splicing sites [13] [14] [15] [16] 24] . This may be explained either by the occurrence of infrequent splicing sites or by the existence of non-spliceosome-mediated trans-splicing mechanisms. The first possibility is plausible because trans-splicing is a rare phenomenon, and it is not unreasonable to conceive of the occurrence of non-canonical splicing sites, as has happened elsewhere [25] . The second possibility is plausible because the hybrid mRNAs might be the result of an alternative RNA processing mechanism which does not use the spliceosome machinery, such as the recently reported tRNA-mediated transsplicing [26, 27] . In this new mechanism, the hybrid mRNA is generated by trans-splicing two complementary pre-tRNA halves joined to two different pre-mRNAs. The authors speculate that 'another feasible way to achieve trans-splicing of mRNAs by tRNA endonuclease is to exploit the vast repertoire of repetitive sequences present in eukaryotic organisms'. Remembering that Short Interspersed Nuclear Elements (SINE) are related to tRNA genes or other RNA Polymerase III-transcribed genes, and that Alu elements constitute the most abundant family of short repeats (SINE), Alu elements may play a major role in trans-splicing in humans and other primates.
The first two examples of human experimental evidence have the same hybrid mRNA pattern: part of their 5 0 UTR came from one chromosome and the remaining sequence from another. This trans-splicing pattern resembles that of the SL category, although the trans-spliced sequence is not usually 'short' and, as already mentioned, neither example follows the splicing site rules, which means that they can not be classified as SL category.
The first human interchromosomal trans-splicing evidence was reported back in 1997 [28] . A truncated isoform of the Ca 2þ /calmodulin-dependent protein kinase II (CaM kinase II) expressed in the human islets of Langerhans was experimentally demonstrated to be a hybrid mRNA formed from one transcript belonging to chromosome 10 and another from chromosome 18. The second example of experimental evidence was the human cholesterol acyltransferase-1 (ACAT-1) hybrid mRNA [29] . Its 5 0 UTR was mapped onto chromosome 7, while the remaining sequence was mapped onto chromosome 1. Its interesting characteristic was the presence of an unusually long 5 0 UTR with 1396 base pairs (bp). Note that the average 5 0 UTR length ranges from 100 to 200 bp [30] . Just as in the preceding case, there were no canonical splicing sites. To rule out the possibility of this hybrid mRNA being a ligation artifact produced during cDNA synthesis in vitro, RT-PCR experiments were performed, and the results were consistent with the trans-splicing hypothesis.
Projects aiming to find new genes and study their expression profiles, or identify new genetic markers such as a single nucleotide polymorphism (SNP), have produced a huge number of publicly available human transcript sequences. The development of novel efficient bioinformatics algorithms has made possible in silico strategies to search for human transsplicing evidence in extremely large databases. The In Silico Trans-splicing Retrieval SystemçISTReS [31] was proposed in order to meet this challenge. Its methodology is quite simple. First, the cDNA database chosen was mapped onto the human genome using BLAST. Then, only those hits that satisfied some predefined criteria were retained. One of its most restrictive criteria was to impose consensus splicing site rules. This criterion is quite controversial, because it plainly excludes both examples of human experimental inter-chromosomal transsplicing evidence mentioned above. Nevertheless, the ISTReS running over the NCBI RefSeq databank found 55 hybrid mRNAs, of which only 21 were from normal tissues. The remaining 34 hybrid mRNAs were from malignant tissues, and it is known that genomic rearrangement frequently occurs in malignant tissues [32] . This last explanation seems to be more reasonable than trans-splicing. Therefore, ISTReS found 21 hybrid mRNAs that might be real instances of human trans-splicing that follow consensus splicing site rules; however, ISTReS misses those instances that do not.
In 2006, using 5 992 495 human-expressed sequence tags (EST) and ad hoc bioinformatics algorithms, several examples of exon repetition, exon scrambling and human trans-splicing were reported [33] . However, in this work, all 15 trans-splicing instances were from cancerous tissue (amelanotic melanoma), which, as the authors recognize, weakens the trans-splicing hypothesis.
These bioinformatics initiatives have proved to be sound and can be successfully applied to search for additional human trans-splicing evidence. Their main challenges are the huge number of sequences and the rarity of the trans-splicing phenomenon that complicates the problem. For this reason, some filtering strategy is unavoidable. Nevertheless, the filtering criteria should incorporate what we have learned so far from the experimental evidence. There are three main lessons, which can be summarized as follows. First, the focus should be on interchromosomal trans-splicing, because the best human experimental evidence belongs to this category. Second, hybrid mRNA is usually formed by a 5 0 UTR (or part of it) from one chromosome and the remaining sequence from another. Third, the occurrence of non-canonical splicing sites means that rare splicing sites may occur by chance, or might be the result of a non-spliceosome-mediated trans-splicing mechanism. None of the human trans-splicing candidate sequences reported so far satisfy those criteria simultaneously.
This work aims to show how to search for hybrid mRNAs in publicly available databases, the characteristics of which resemble those of the best human experimental trans-splicing evidence. It is worth noting that the trans-splicing fusion point may occur in coding sequences (CDS) and 3 0 UTR, and our methodology is intended to deal with these cases as well.
MATERIALS AND METHODS
In the following paragraphs, we describe our in silico methodology for searching for human trans-splicing evidence that considers the three lessons mentioned above. Considering that the supposed novel interchromosomal trans-splicing mechanism is still under investigation, we do not claim that our methodology can identify all categories of interchromosomal transsplicing, although it successfully finds some instances, the characteristics of which are similar to those reported in experiments.
Database
The choice of database is no easy task, as there are plenty of options available. Each database has its own characteristics; consequently, it is critical to state which characteristics are most relevant to our point of view. Definitely, the transcript structure information, i.e. 5
0 UTR-CDS-3 0 UTR, is fundamental. Therefore, we decided to use a curated full-length cDNA (FLcDNA) library instead of an EST library, the sequences of which are shorter and significantly more redundant.
In 2004, an international collaborative project [34] 0 UTR are found in a distinct chromosome. In other words, we are looking for a particular trans-splicing type: interchromosomal. We do not impose splicing site rules.
Trans-splicing candidates
Our methodology is detailed in Figure 1 Figure 1 and double-checked using BLAT [35] ). The result was saved in three XML alignment files. The XML file corresponding to 5 0 UTR was cross-matched (GeneAlignmentAnalyser) to the CDS and the 3 0 UTR XML files. We retained only those sequences where TSRs were located in only a single chromosome and nowhere else, in order to avoid ambiguities in interpretation. Only these hybrid mRNAs were stored in the TransSpl file. 
RESULTS
We found 16 hybrid mRNAs (Table 1) , the characteristics of which resemble those of the best human experimental trans-splicing evidence. As described in the Materials and Methods section, in order to avoid interpretational ambiguities, all the candidate hybrid mRNAs had their TSRs mapped onto only one single chromosome locus and nowhere else. Although the second case of experimental evidence suggested looking for transcripts with exceptionally long 5 0 UTR (like ACAT-1 5 0 UTR with 1.396 bp), our methodology found four candidate sequences with 5 0 UTR shorter than 400 bp.
Remarkably, there is no intersection between our candidate list and the ISTReS'. The cDNA database differences may be part of the explanation. There is, however, another reason that seems to be more significant: we did not impose canonical splice sites, and, interestingly enough, none of our candidate sequences follows them ( Table 2) . We speculate that this is related to the fact that our methodology was designed to look for a very specific trans-splicing category, i.e. interchromosomal trans-splicing, where the TSR belongs exclusively to 5 0 UTR. Perhaps this type of trans-splicing does not make use of canonical splicing sites or spliceosome machinery.
We double-checked the sequence quality with regard to external contamination, and found no vectorial, mitochondrial, or bacterial contamination. Unfortunately, although H-InvDB is a highly curated database, we cannot exclude the possibility that some hybrid mRNAs were produced by cloning or other experimental artifacts; however, four independent candidate sequences belong to the same H-InvDB cluster, which minimizes the probability of cloning or experimental artifacts.
We looked for evidence that the TSRs were actually transcribed. Using UCSC BLAT [35] , each TSR was mapped back onto the human genome, and, using the UCSC Genome Browser, we identified annotated genes in the TSRs' genomic regions. Considering the 16 TSRs in Table 3 , we arrived at two distinct cases: (i) 12 TSRs were mapped onto known gene loci (Figure 2 shows TSRs mapped onto exons, and Figure 3 , TSRs mapped onto introns); (ii) four TSRs (actually, there is only one non-redundant TSR) were mapped onto a Human Endogenous Retrovirus (HERV-K) genomic region ( Figure 4 ).
For example, the transcript with accession number [DDBJ:AK124366] is almost completely mapped onto chromosome 8. However, part of its 5 0 UTR came from chromosome 5, and it belongs to the 3 0 UTR of an antisense gene (PPP2CA), the accession number of which is [GenBank:NM_002715]. This sense/antisense transcript pattern resembles the trans-splicing mechanism mediated by repetitive sequences [16] . We developed ad hoc software to look for short, inverted repeats that could mediate the trans-splicing event in both mRNA genomic regions. Although we found several almost perfect inverted repeats in all cases, in order to visualize some examples, we considered only those inverted repeats with at least 250 bp and with high sequence identity ( Figure 5 ). We can see that, in some cases, there are so many inverted repeats that it is difficult to interpret the graphical representation. It is worth noting that most of the inverted repeats identified are actually Alu repeats.
The TSRs that were mapped onto a HERV-K genomic region are the most interesting and deserve special discussion. The UCSC Genome Browser indicated only LINE elements in the TSRs' locus. In order to confirm the presence of an active transcript, using BLAT, we mapped these TSRs onto the human genome, with the aim of obtaining expanded sequences (considering 100 kbp up-and down-stream of each mapped sequence). Applying validated gene prediction software, GeneMark [36] , we found several putative amino acid sequences, some of which were actually similar to the retrovirus structure (gag-pol-env), in this case, the Human Endogenous Retrovirus K (HERV-K), which is an active human endogenous retrovirus active in the human organism [37] . We acknowledge that this is not strong evidence of transcription, because the information that HERV-K is an active mobile genetic element may suggest that the TSR is actually transcribed. However, as we are considering the reference genome only and HERV-K is a repetitive sequence, it is also possible that a new insertion has occurred which placed it into the existing gene, in which case, we would have no trans-splicing event at all. Nevertheless, as will be discussed below, two independent laboratories have indentified this hybrid mRNA. Thus, either a new insertion in the existing gene has occurred or a trans-splicing event has occurred, in both cases further investigation is required. [39] .
DISCUSSION H-InvDB cluster HIX0019725
This cluster is associated with GPCR, family 3, a metabotropic glutamate receptor-like gene family. Their TSRs are mapped onto chromosome 19 (associated with HERV-K), while the remaining sequence is mapped onto chromosome 3. Their 5 0 UTR sequence has 451 bp, where the initial 303 bp form the TSR. However, only 296 bp from the TSR sequence were successfully mapped onto chromosome 19. The initial 7 bp were missing. Its TSR belongs to a well studied human endogenous retrovirus (HERV-K). These retrovirus' transcripts are found in every human tissue and they are still active. Unfortunately, the fact that HERV-K is still an active mobile element may jeopardize the hypothesis of trans-splicing event, because it is equally possible that a new insertion has occurred which placed the HERV-K into the GPCR genomic region in chromosome 3. Further investigation is required in order to decide which phenomenon has actually occurred.
Assuming that no new HERV-K insertion has occurred and considering the rarity of the trans--splicing phenomenon, the occurrence of four instances of candidate sequences in the same cluster is surprising for two reasons: first, because the sequences were deposited by two independent groups, implying that this phenomenon is recurrent and specific; second, considering the full length cDNA construction library methodology, the probability of laboratorial artifacts is reduced considerably.
A representative case: FLRT2
There is a single candidate sequence, accession number [DDBJ:AB007865], that most resembles the ACAT-1 trans-splicing pattern [29] . It is a human fibronectin leucine-rich transmembrane protein 2 (FLRT2) [40] , the transcript structure of which is depicted in Figure 6 . This transcript belongs to the H-InvDB Cluster HIX0011865, which contains six FLcDNA sequences of the FLRT2 gene, but only sequence HIT00000122 (AC [DDBJ:AB007865]) might be an interchromosomal trans-splicing candidate ( Figure 7) . All CDS and 3 0 UTRs were successfully mapped onto chromosome 14 (location 14q31.3) with high identity and coverage scores. The chromosome 14 assemblage has been completed [41] , i.e. a single continuous segment with no gaps; there are 87 410 661 bps, representing its whole euchromatic portion in a single scaffold. The sequence HIT00000122 is the longest one in the H-InvDB Cluster 0 UTR have been mapped onto chromosome 4 with high (100%) identity, and no other part of it was found in other chromosomes. As reported earlier, its TSR was found within an intron belonging to an antisense gene (KCNIP4).
CONCLUSION
In this work, we have shown a methodology for searching for hybrid mRNAs, the characteristics of which most resemble those of the best experimental assay. For illustrative purposes, we used a curated human FL-cDNA database, selected filtering criteria that were supported by experimental evidence, and we successfully found 16 human hybrid mRNAs. It is worth noting that in humans, except in a single case, the interchromosomal trans-splicing mechanism does not follow consensus splicing site rules similar to the standard cis-splicing mechanism; however, these rules have been extensively applied in other screening methodologies, which partially explains why none of our candidates had been previously identified. This result may indicate that trans-splicing, although rare, may be more widespread than believed. Given that none of our candidate sequences follows canonical splicing sites, either infrequent splicing sites occur under special conditions or a non-spliceosome-mediated trans-splicing mechanism may be involved, such as the recently reported tRNA-mediated trans-splicing mechanism. Moreover, both genomic regions of the candidate sequences and their associated transcripts have complementary inverted repeats (predominantly Alu elements) that might be involved in a possible non-spliceosome-mediated trans-splicing mechanism, as conjectured in ref. [26] .
Our trans-splicing candidate sequences are supposedly from normal tissues, and a recent study [42] has reported that trans-splicing may occur not only in malignant tissues, but in normal tissues as well, which is in agreement with our in silico findings.
Finally, despite the fact that our methodology was developed using human data, it can also be applied to other organisms, and the choice of 5 0 UTR to search for trans-splicing events, although supported by experimental assays, was intended for illustrative purposes only. It is clear that trans-splicing events may also occur in CDS or 3 0 UTR, and our methodology is intended to deal with these cases as well.
Key Points
Trans-splicing may be mediated by tRNA without the spliceosome machinery, which means that non-canonical splicing sites may occur. Trans-splicing is not only present in malignant tissues, but in normal tissues as well. A screening pipeline may be easily applied to other databanks to search for trans-splicing candidates in other organisms. The bioinformatics methodologies published so far did not take these findings into account, which partially explains why none of our candidate sequences was reported earlier. 
